Bleakley Financial Group LLC Increases Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)
Bleakley Financial Group LLC increased its position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 262.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,296 shares of the company’s stock after acquiring an additional 34,984 shares during the period. Bleakley […]
Bleakley Financial Group LLC increased its position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 262.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,296 shares of the company’s stock after acquiring an additional 34,984 shares during the period. Bleakley […]
